I'm a title. Click here to edit me.
Adar Poonawalla (born on 14 January 1981), is the Chief Executive Officer (CEO) of Serum Institute of India. Founded in 1966 by his father Dr. Cyrus Poonawalla, it is the world’s largest vaccine manufacturer by the number of doses produced, as of 2017.
He was also listed as one of the 50 most influential young Indians by the GQ Magazine and also was awarded Philanthropist of the year in 2016.
He moved into this role following 11 years as the company’s president and chief executive officer. Ajay is a co-founder of The Cyber Readiness Institute, chairman of the International Chamber of Commerce and a trustee of the United States Council for International Business. Ajay is a founding trustee of the U.S.-India Strategic Partnership Forum, a member of the U.S.-India CEO Forum and is chairman emeritus of the American India Foundation. He served as a member of President Obama’s Commission on Enhancing National Cybersecurity. He is a past member of the U.S. President’s Advisory Committee for Trade Policy and Negotiations.
He was awarded the Padma Shri Award by the President of India in 2016, the Ellis Island Medal of Honor in 2019 and the Business Council for International Understanding’s Global Leadership Award. He is a fellow of the Foreign Policy Association and was awarded the Foreign Policy Association Medal in 2012.
Ajay is a member of the Weill Cornell Medicine board of fellows. In addition, Ajay serves as a director of Dow Inc. and is a member of its compensation and governance committees.
Prior to Mastercard, Ajay served as chief executive officer of Citigroup Asia Pacific. During his career at Citigroup, he held a variety of senior management roles in the United States, Asia Pacific, Europe, Middle East and Africa. He also oversaw the company’s efforts in microfinance.
Ajay began his career at Nestlé, India, where for 13 years he worked on assignments spanning sales, marketing and general management. He also spent two years with PepsiCo, where he was instrumental in launching its fast food franchises in India as the economy liberalized.
Anil Kumar SG is the Founder and CEO of Samunnati Financial Intermediation & Services Private Limited (Samunnati). Anil is a career banker with over 28 years of experience in the areas of Rural, Retail and Agri Banking. He started his career with Canara Bank and then joined ICICI Bank. Over the last decade, Anil’s work was focused on creating newer institutions across the country and operating in the financially excluded markets with corresponding support structures for their capacity building. Prior to Samunnati, Anil was the Co-Founder & Trustee of IFMR Trust and the CEO of IFMR Rural Channels.
She fills a key role in developing CDPQ’s activities in its three priority international areas: the United States/Latin America, Europe and Asia Pacific. She actively participates in positioning CDPQ internationally, as well as developing and executing its globalization strategy. In addition to her role managing the international offices, Ms. George contributes to diversifying the portfolio by taking a holistic view in approaching the various markets. She sits on CDPQ’s Investment-Risk Committee.
Ms. George joined CDPQ in April 2016 as Managing Director, South Asia. She was then appointed as Executive Vice-President, Growth Markets and prior to her current role was Executive Vice-President and Head of Strategic Partnerships, Growth Markets. She has extensive knowledge of several of these markets, in addition to possessing a strong ability to develop and strengthen enduring and quality partnerships.
She has a strong track record in managing infrastructure investment portfolios on a global scale. Prior to joining CDPQ, she was Senior Director of the World Bank’s Energy and Extractive Industries Global Practice. She also held the positions of Director, Infrastructure and Natural Resources of the International Finance Corporation, a member of the World Bank Group, and Head of Siemens Financial Services in India. Her various roles have led her to work in several regions of the world, including Europe, Asia, the Middle East, Africa and Latin America.
Ms. George holds a BA in Economics and Spanish from Smith College, in Massachusetts, and a Masters in Economics and an MBA in Finance from Boston University.
Anuradha Gupta is Deputy Chief Executive Officer of Gavi, the Vaccine Alliance. Since joining Gavi in 2015, Anuradha has led efforts to put equity and gender at the centre of Gavi’s programmatic planning and to tailor support to countries within Gavi’s strategy. She has also driven efforts to create a new model of country-level Alliance support, through the establishment of the partners’ engagement framework (PEF). At the same time, Anuradha has helped to improve country ownership and leadership of Gavi-supported programmes while enhancing accountability for results. In 2019, Gavi received the prestigious Lasker~Bloomberg Public Service Award for providing sustained access to childhood vaccines in the world’s poorest countries, saving millions of lives and highlighting the power of immunisation to prevent diseases.
Prior to Gavi, Anuradha served as Mission Director of the National Health Mission of India, where she ran the largest – and possibly most complex – public health programme in the world with an annual budget of US$ 3.5 billion. A passionate and influential advocate of women, young girls and children, Anuradha played a leading role in India’s efforts to eradicate polio transmission, reduce maternal and child mortality and revitalise primary health care.
Anuradha has contributed towards a number of important global health initiatives. She served as a member of the Steering Committee for Child Survival Call to Action, co-chaired the Stakeholder Group for the 2012 London Summit on Family Planning and was a member of the Family Planning 2020 (FP2020) Reference Group. Anuradha served as Co-Chair of the Partnership for Maternal, Newborn & Child Health (PMNCH) and is currently a member of the PMNCH Board. She also played a role in shaping the Global Financing Facility (GFF) and is a member of the GFF Investors Group. From 2015-2018, Anuradha served on the Merck for Mothers Advisory Board.
Anuradha holds an MBA from the University of Wollongong in Australia and received executive education from the John F. Kennedy School of Government at Harvard University, Stanford Graduate School of Business and Maxwell School of Citizenship and Public Affairs at Syracuse University. In 2015, she was named one of “300 Women Leaders in Global Health” by the Global Health Centre of the Graduate Institute of International and Development Studies.